banner
Reference Listed Drugs
Eylea 40mg/ml Aflibercept Intravitreous Injection Reference Listed Drug

Eylea 40mg/ml Aflibercept Intravitreous Injection Reference Listed Drug

Eylea is suitable for the treatment of adults with: neovascular (wet) age-related macular degeneration (nAMD); Diabetic macular edema (DME). For R&D purposes only.

Product Details

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

 

Generic name Aflibercept Intravitreous Injection
Trade name Eylea
Specification 40mg/ml
Main ingredients Aflibercept
Appearance This product is a clear, colorless to yellowish isotonic solution.
MA Holder Bayer AG
Manufacturer Vetter Pharma-Fertigung GmbH & Co.KG

 

 

 

Indications:

This product is suitable for the treatment of adults with: neovascular (wet) age-related macular degeneration (nAMD); Diabetic macular edema (DME).

 

 

Eylea-1

 

 

 

 

Eylea-2

 

 

 

For more details,pls contact Janney:

Email: tosun-global@upharm.cn

Wechat/Whatsapp:(+86)18922120575

 

 

Hot Tags: Eylea 40mg/ml Aflibercept Intravitreous Injection Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Bimatoprost Ophthalmic, Argatroban Injection, Adefovir Dipivoxil Tablets, Olanzapine Tablets, Agomelatine Tablets, Reference Listed Drugs

Send Inquiry
Verification Code: